Moreforme can you expand on the three dot.points you make I assume you are only speaking of " Leukaemia link" but my belief is Hansen Inst...... are dealing with CSL as per .................. “To maximise the drug development opportunities of this discovery both Institutes have recently
signed an agreement with biopharmaceutical company CSL Limited. Under the agreement the
Institutes will work with CSL to discover and develop new therapeutic antibodies”.....I have not read in ten years where scientists are on a retainer to MSB if that is the case , the market does not know and it should , and who paid for the rights ( Itescu and partners) ?? put up some more info please and I will follow it up .. Cheers V
r&d spend - quarterly to 31 mar '13, page-4
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |